title: [Efficacy of immunovenin in patients with community-acquired pneumonia].
abstract: OBJECTIVE
  To study efficacy of human immunoglobulin for intravenous administration (immunovenin) in the treatment of patients with community-acquired pneumonia (CAP).
  
  
  METHODS
  Two groups of CAP patients participated in the trial. Group 1 (n = 35) received standard therapy. Group 2 (n = 33) received standard therapy plus immunovenin.
  
  
  RESULTS
  CAP patients had immune disorders. Combined treatment of CAP with administration of immunovenin relieved clinical symptoms of the disease, improved immunological status. Group 1 patients demonstrated symptoms of the disease and defects in immunity for a long time.
  
  
  CONCLUSIONS
  Addition of immunovenin to standard therapy of CAP improves immunological parameters, efficacy of CAP treatment.
mesh_terms: D000328:Adult; D017714:Community-Acquired Infections / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000188:drug therapy* / Q000276:immunology
chemical_list: D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors